The Trump administration’s effort to remake the federal workforce swept through US healthcare agencies on Friday, with wide ...
Johnson & Johnson is set to push for confirmation of a bankruptcy plan next week that would settle a vast majority of cases ...
Major drugmakers are planning to meet with President Donald Trump next week at the White House as part of the industry’s ...
Kojin Therapeutics, a startup attempting to develop new treatments using programmed cell death, left last month’s JP Morgan ...
Corbus' CRB-701 shows 23% response rate in early cancer trial, but shares fall after some patients with prior Padcev ...
West Pharmaceuticals stock drops 38% after ending glucose monitor contracts; CEO Eric Green says GLP-1 business will offset ...
Bambusa Therapeutics raises $90M Series A for bispecific antibodies, led by RA Capital. Founded by BioNTech veterans, plans ...
About two and a half years before they sealed a $3.3 billion deal, Bain Capital and its life sciences team started courting ...
Renee Wegrzyn has been let go as the head of a federal agency that pursues ambitious ideas to accelerate biomedical innovation, part of a broad series of ongoing changes being made by the new Trump ...
David Schenkein will step down from Agios Pharmaceuticals ’ board of directors at the end of the month “to devote more ...
Moderna is working on restoring investors' faith that its Covid-19 vaccine was not a one-hit-wonder. It also has to show it ...
A series of actions by President Donald Trump's administration have provoked profound anxiety among academic labs that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback